Distrimex. Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Distrimex. Pharmaceutical Import Records from India — 4 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Distrimex. — Pharmaceutical Importer Profile (2026) | 4 Products, $3.8M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Distrimex.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Strides Pharma Science Limited	$6.0M	332	44.8%
Subira Pharmaceuticals Private Limited	$2.4M	203	17.6%
Glenmark Pharmaceuticals Limited	$1.4M	60	10.3%
Saimirra Innopharm Private Limited	$724.5K	80	5.4%
Cachet Pharmaceuticals Private Limited	$682.8K	99	5.1%
Corona Remedies Private Limited	$655.3K	76	4.9%
Asmoh Laboratories Limited	$554.0K	46	4.1%
Sefier Life Science Private Limited	$298.4K	38	2.2%
Morsef Pharmaceuticals Private Limited	$146.6K	13	1.1%
Corona Remedies Limited	$138.6K	9	1.0%
Coral Laboratories Limited	$106.7K	16	0.8%
Sance Laboratories Private Limited	$80.5K	10	0.6%
Ciron Drugs And Pharmaceuticals Private Limited	$51.4K	5	0.4%
Richmel Life Sciences Private Limited	$48.4K	8	0.4%
Careth Corporation	$47.9K	11	0.4%
Kaiser Exports	$42.8K	7	0.3%
Aculife Healthcare Private Limited	$32.2K	5	0.2%
Fdc Limited	$28.0K	32	0.2%
Glendale Biomed Private Limited	$27.7K	3	0.2%
Lob International	$7.3K	1	0.1%
London United Medimpex Private Limited	$6.9K	1	0.1%

Distrimex. sources from 21 verified Indian suppliers across 654 distinct formulations. The supply base is diversified across 21 suppliers, reducing single-source dependency risk.

What Formulations Does Distrimex. Import?

Formulation	Value	Ships
Vitafer forte syrup of iron and folic	$673.5K	19
Paluva cpr 80/480MG (bt6)(antimalarial	$666.7K	21
Clavicin foi-1g/200MG amoxicillin &	$200.0K	4
Solcer - omeprazole for injection 40MG [Pack of x	$192.5K	5
Paluva 80MG INJ 1x6s -details as per invoice no 409/sub/dis/2024 dt	$169.4K	8
Celltriaxon 1g-ceftriaxone injection	$168.8K	4
Solcer-omeprazole for injection 40MG	$128.2K

What Products Does Distrimex. Import?

Top Products by Import Value

1Folic$2.5M 2Vitamin$1.1M 3Secnidazole$115.2K 4Ceftazidime$95.0K

Distrimex. Therapeutic Categories — 2 Specializations

Distrimex. imports across 2 therapeutic categories, with Nutritional Supplements (94.5%), Advanced Antibiotics (5.5%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Folic	Nutritional Supplements	$2.5M	82	2.4%	4
2	Vitamin	Nutritional Supplements	$1.1M	23	0.8%	12

Key Metrics

Total Import Value$3.8M

Products4

Shipments111

Categories2

CountryFrance

#1 Rankings0

Indian Suppliers21

Formulations654

Top Categories

Nutritional Supplements94.5%

Advanced Antibiotics5.5%

Last updated: March 28, 2026

Distrimex. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Distrimex is a French company specializing in the import and export of fresh fruits and vegetables. Established in 1975 by Mr. Hubert Casal, the company has become a key player in its sector, distributing approximately 50,000 tonnes of produce annually across the globe. Their product range includes apples, pears, apricots, plums, peaches, nectarines, and various other fruits and vegetables. (distrimex.fr)

In 2010, Distrimex expanded its operations by establishing a subsidiary, DISTRIMEX, under the CERP Bretagne Atlantique group. This subsidiary focuses on the distribution, promotion, and regulatory affairs of pharmaceutical and parapharmaceutical products in French and English-speaking African countries, as well as in the French overseas departments, regions, and municipalities (DROM-COM). DISTRIMEX offers logistics expertise and supports laboratories in their business development strategies and interactions with local health authorities.

2Distribution Network

DISTRIMEX operates a bonded warehouse certified by the French National Agency for the Safety of Medicines and Health Products (ANSM). This facility ensures compliance with Good Wholesaler Distribution Practices (GDP) and maintains product storage in a temperature-controlled environment ranging from +15°C to +25°C. The company manages over 1,000 pallets per month, serving 55 clients across 22 territories.

Supplier Relationship Intelligence — Distrimex.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

DISTRIMEX's sourcing strategy for pharmaceutical products involves a diverse range of suppliers, with a total of 21 unique Indian suppliers identified in the trade data. The top five suppliers account for 77.1% of the total import value, indicating a moderate level of concentration. This distribution suggests that while DISTRIMEX relies heavily on a few key suppliers, it also maintains relationships with a broader network of suppliers, which can help mitigate risks associated with single-source dependency.

The shipment data reveals a stable relationship with these suppliers, as evidenced by the consistent number of shipments over the years. For instance, STRIDES PHARMA SCIENCE LIMITED has 332 shipments valued at $6.0 million, and SUBIRA PHARMACEUTICALS PRIVATE LIMITED has 203 shipments valued at $2.4 million. This consistency indicates a reliable supply chain and suggests that DISTRIMEX has established strong partnerships with these suppliers.

2Supply Chain Resilience

DISTRIMEX's supply chain resilience is supported by its diverse sourcing strategy, involving 21 unique Indian suppliers. This diversity reduces the risk associated with dependency on a single supplier and enhances the company's ability to adapt to potential disruptions. The consistent number of shipments from these suppliers over the years indicates stable and reliable relationships, further strengthening the supply chain's resilience.

However, the supply chain's resilience could be further enhanced by identifying and establishing relationships with additional backup suppliers. This would provide alternative sources in case of unforeseen disruptions. Additionally, increasing the diversity of imported formulations beyond the current four products could help mitigate risks associated with over-reliance on a limited product range.

3Strategic Implications

DISTRIMEX's sourcing pattern, characterized by a moderate concentration on a few key suppliers and a diverse supplier base, positions the company to effectively manage supply chain risks while maintaining strong supplier relationships. For Indian exporters, this pattern presents an opportunity to establish partnerships with DISTRIMEX, especially if they can offer products that complement the existing portfolio or provide competitive advantages.

To become alternative suppliers to DISTRIMEX, Indian exporters should focus on product quality, regulatory compliance, and the ability to meet the logistical requirements of the French and African markets. Building a reputation for reliability and consistency will be crucial in gaining DISTRIMEX's trust and securing a position in their supply chain.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the National Agency for the Safety of Medicines and Health Products (ANSM). ANSM is responsible for ensuring the safety, efficacy, and quality of health products available in the French market. Key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for marketing authorization, importation, and distribution of pharmaceutical products.

The marketing authorization pathway for Indian generics involves obtaining a Marketing Authorization (AMM) from ANSM. This process includes submitting a comprehensive dossier demonstrating the product's quality, safety, and efficacy. The dossier must comply with the European Medicines Agency (EMA) guidelines and may require additional data specific to the French market. Collaboration with local regulatory experts can facilitate this process and ensure compliance with all regulatory requirements.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in France are stringent. Importers must hold a wholesale distribution authorization issued by ANSM, which requires compliance with Good Distribution Practices (GDP). Additionally, imported products must be manufactured in facilities that adhere to Good Manufacturing Practices (GMP). The EU recognizes GMP certificates from countries with equivalent standards, such as WHO GMP and PIC/S certifications.

For Indian exporters, obtaining GMP certification from recognized bodies is essential to meet the import requirements of France. This certification ensures that manufacturing processes meet the quality standards expected in the European market. Additionally, importers must ensure that their products comply with all applicable regulations, including labeling, packaging, and storage conditions.

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to ensure they meet the quality standards set by ANSM. Stability requirements are also critical, as products must maintain their efficacy and safety throughout their shelf life. Labeling must be in French and include all necessary information, such as dosage instructions, side effects, and storage conditions. Serialization mandates may apply to facilitate traceability and prevent counterfeit products.

Indian exporters should ensure that their products meet these quality and labeling requirements to facilitate smooth entry into the French market. This includes conducting thorough quality control tests, ensuring compliance with stability protocols, and providing accurate and comprehensive labeling in French.

4Recent Regulatory Changes

Between 2024 and 2026, several policy changes have affected Indian pharmaceutical imports into France. These include stricter enforcement of GMP compliance, updates to labeling requirements to enhance patient safety, and the introduction of new serialization mandates to combat counterfeit drugs. Additionally, there have been changes in the approval process for marketing authorizations, with increased scrutiny of clinical data and manufacturing processes.

Indian exporters must stay informed about these regulatory changes to ensure continued access to the French market. Engaging with regulatory consultants and participating in industry forums can provide valuable insights into these developments and assist in maintaining compliance.

TransData Nexus Research · France regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Distrimex. identified across shipments using consignee name normalization, aggregating 3 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Distrimex.'s capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 111 individual customs records matching Distrimex..
5.Supplier Verification: Distrimex. sources from 21 verified Indian suppliers across 654 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Products Tracked

2 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Distrimex.

Distrimex. — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Distrimex.?

What Formulations Does Distrimex. Import?

What Products Does Distrimex. Import?

Top Products by Import Value

Distrimex. Therapeutic Categories — 2 Specializations

Import Portfolio — Top 4 by Import Value

Key Metrics

Top Categories

Distrimex. — Corporate Profile & Information

1Company Overview

2Distribution Network

Indian Suppliers

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Distrimex.

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into France — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Distrimex. — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

Frequently Asked Questions — Distrimex.

What products does Distrimex. import from India?

Who supplies pharmaceuticals to Distrimex. from India?

What is Distrimex.'s total pharmaceutical import value?

What therapeutic categories does Distrimex. focus on?

Get Full Distrimex. Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology